• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

United kingdom: An imported case of lassa fever in a traveller from nigeria. (hpa)

Giuseppe

Emeritus
HPA - Case of Lassa Fever in Specialist Unit in London

Case of Lassa Fever in Specialist Unit in London

23 January 2009

The Health Protection Agency can confirm that a patient is being treated for Lassa fever at the high security infectious diseases unit at the Royal Free Hospital.


This is an isolated case in a traveller who returned to the UK, from Nigeria, on the 6th January.

There is no risk to the general public as a result of this case.

The patient was initially admitted to Homerton University Hospital on 8th January, and then transferred to the Hospital for Tropical Diseases, University College Hospital on 22nd January.

The Homerton carried out testing for a wide range of common infections associated with travel to Africa, all of which tested negative.

Following this samples were referred to the Health Protection Agency and the diagnosis of Lassa fever was made on the 22nd January.

At this point the patient was moved to the Royal Free where they could receive the appropriate treatment.

Dr Dilys Morgan a Lassa fever expert at the Health Protection Agency said;

"This is an isolated case of Lassa fever in a traveller who has recently returned from Nigeria. It is important to stress that there is no risk to the general public from this patient."

Lassa fever is an infection that is found in West Africa and is seen rarely in this country in those who have travelled to parts of the world where it is common. The infection is not easily spread to others and then only by direct contact with bodily fluids.

The usual incubation period for Lassa fever is 7-10 days.

The symptoms include a fever, headache, sore throat, cough, nausea, vomiting, diarrhoea and muscle pain.

"We are working closely with Homerton University Hospital and the Hospital for Tropical Diseases, University College Hospital to identify any members of staff who may have been involved in the care of this patient, and who came into contact with their bodily fluids. These people will be provided with information about Lassa fever and asked to get in contact with us should they develop any symptoms. Patients and visitors to the hospital are not at risk"

Notes to Editors:
Lassa fever is an acute illness caused by Lassa virus and known to be endemic in Nigeria, Sierra Leone, Liberia, Guinea and the Central African Republic, and there is evidence of infection in nearby countries including Mali, Senegal, and the Democratic Republic of Congo.

The virus is shed in the urine and droppings of infected rats so most infections arise through contact with materials contaminated by these.

Information on Lassa fever and other viral haemorrhagic fevers can be found at www.hpa.org.uk/infections/topics_az/VHF/menu.htm
Information about the condition of the patient can be obtained from the Royal Free Press Office on 0207 830 2963 for more information about the Royal Free high security infectious diseases unit please go to: http://www.royalfree.nhs.uk/default.aspx?top_nav_id=1&tab_id=453
For further information please contact the press office on 0207 759 2824/2834.
For out of hours calls please phone 0208 200 4400.
Last reviewed: 23 January 2009
-
<cite cite="http://www.hpa.org.uk/webw/HPAweb&HPAwebStandard/HPAweb_C/1232698039715?p=1231252394302">HPA - Case of Lassa Fever in Specialist Unit in London</cite>
 
Re: United kingdom: An imported case of lassa fever in a traveller from nigeria. (hpa)

LASSA FEVER - UNITED KINGDOM ex NIGERIA
***************************************
A ProMED-mail post
<http://www.promedmail.org>
ProMED-mail is a program of the
International Society for Infectious Diseases
<http://www.isid.org>

Date: Fri 23 Jan 2009
Source: Channel 4 News, PA News [edited]
<http://www.channel4.com/news/articles/society/health/africa+traveller+has+lassa+fever/2909847>


Africa traveller has Lassa fever
--------------------------------
A patient is being treated in hospital for Lassa fever, which can
cause deafness [among other things], a health watchdog said. The
patient travelled in Nigeria before returning to the United Kingdom
(UK) and is now being treated at the high security infectious
diseases unit at the Royal Free Hospital in north London. The Health
Protection Agency (HPA) said the patient, whose gender is not being
disclosed, represented an isolated case and there was no risk to the
general public.

Lassa fever is caused by Lassa virus and is endemic in Nigeria,
Sierra Leone, Liberia, Guinea and the Central African Republic.
Hundreds of thousands of people are infected in these countries each
year and isolated cases have been seen in Europe and the US [imported
from Africa - Mod.CP]. Infection also occurs in other African
countries including Mali, Senegal and the Democratic Republic of Congo.

Around 8 in 10 people infected with Lassa virus develop mild or no
symptoms, but in 20 percent of cases people will have severe illness.
Symptoms include fever, headache, sore throat, a cough, nausea,
vomiting, diarrhoea and muscle pain. Around 2 percent of all patients
die from the illness and death rates are particularly high in women
in the final months of pregnancy. A common complication of Lassa
fever is deafness.

--
Communicated by:
HealthMap Alerts via ProMED-mail
<promed@promedmail.org>

[Lassa viral haemorrhagic fever is an acute illness of 1-4 weeks
duration that occurs in West Africa. Though 1st described in the
1950s, the virus causing the disease was not identified until 1969.
The virus is a single-stranded RNA virus belonging to the virus
family _Arenaviridae_. Lassa fever is known to be endemic in Guinea
(Conakry), Liberia, Sierra Leone and parts of Nigeria, but probably
in other West African countries as well.

Lassa fever is a zoonotic disease, meaning that humans become
infected from contact with infected animals. The animal reservoir of
Lassa virus is a rodent of the genus _Mastomys_, commonly known as
the "multimammate rat." Mastomys infected with Lassa virus do not
become ill, but they can shed the virus in their excreta (urine and faeces).

Lassa fever occurs in all age groups and in both men and women.
Persons at greatest risk are those living in rural areas where
Mastomys are usually found, especially in areas of poor sanitation or
crowded living conditions. Health care workers are at risk if proper
barrier nursing and infection control practices are not maintained.

Family members and health care workers should always be careful to
avoid contact with blood and body fluids while caring for sick
persons. Routine barrier nursing precautions probably protect against
transmission of Lassa virus in most circumstances. However, for added
safety, patients suspected to have Lassa fever should be cared for
under specific "isolation precautions," which include the wearing of
protective clothing such as masks, gloves, gowns, and face shields,
and the systematic sterilization of contaminated equipment. The
antiviral drug ribavirin is effective treatment for Lassa fever if
given early on in the course of clinical illness.

Further information can be obtained from the World Health
Organisation Web site at:
<http://www.who.int/mediacentre/factsheets/fs179/en/index.html>. - Mod.CP]

[A map showing the countries in West Africa mentioned above is
available at:
<http://everythingspossible.files.wordpress.com/2008/03/map-west-africa.jpg>
- Copyed.EJP]

[see also:
2008
----
Lassa fever - Nigeria (02 20080611.1847
Lassa fever - Nigeria: (Ebonyi) 20080323.1100
2007
----
Lassa fever - Nigeria 20071205.3925
Lassa Fever - South Africa ex Nigeria 20070222.0657
205
----
Lassa fever - Nigeria (Edo) 20050303.0654
Lassa fever - Nigeria (Edo) 20040214.0487
Lassa fever - Nigeria: RFI 20040213.0482
2001
----
Lassa fever, suspected - Nigeria (Edo) (02) 20010319.0552
Lassa fever, suspected - Nigeria (Edo): RFI 20010315.0524
2000
----
Lassa fever - Germany ex Nigeria (03) 20000424.0609
Lassa fever - Germany ex Nigeria (02) 20000405.0497
Lassa fever - Germany ex Nigeria 20000404.0495]
-
http://apex.oracle.com/pls/otn/f?p=..._BACK_PAGE,F2400_P1001_PUB_MAIL_ID:1000,75749
------
....................mpp/cp/ejp/mpp
</pre>
 
Back
Top Bottom